UniProt ID | MBD2_HUMAN | |
---|---|---|
UniProt AC | Q9UBB5 | |
Protein Name | Methyl-CpG-binding domain protein 2 | |
Gene Name | MBD2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 411 | |
Subcellular Localization | Nucleus . Nuclear, in discrete foci. Detected at replication foci in late S phase. | |
Protein Description | Binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binds hemimethylated DNA as well. Recruits histone deacetylases and DNA methyltransferases. Acts as transcriptional repressor and plays a role in gene silencing. Functions as a scaffold protein, targeting GATAD2A and GATAD2B to chromatin to promote repression. May enhance the activation of some unmethylated cAMP-responsive promoters.. | |
Protein Sequence | MRAHPGGGRCCPEQEEGESAAGGSGAGGDSAIEQGGQGSALAPSPVSGVRREGARGGGRGRGRWKQAGRGGGVCGRGRGRGRGRGRGRGRGRGRGRPPSGGSGLGGDGGGCGGGGSGGGGAPRREPVPFPSGSAGPGPRGPRATESGKRMDCPALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLARYLGNTVDLSSFDFRTGKMMPSKLQKNKQRLRNDPLNQNKGKPDLNTTLPIRQTASIFKQPVTKVTNHPSNKVKSDPQRMNEQPRQLFWEKRLQGLSASDVTEQIIKTMELPKGLQGVGPGSNDETLLSAVASALHTSSAPITGQVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADILSRAADTEEMDIEMDSGDEA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Methylation | ------MRAHPGGGR ------CCCCCCCCC | 41.42 | 54557259 | |
19 | Phosphorylation | PEQEEGESAAGGSGA CCCCCCCCCCCCCCC | 33.99 | 23927012 | |
24 | Phosphorylation | GESAAGGSGAGGDSA CCCCCCCCCCCHHHH | 25.26 | 23927012 | |
30 | Phosphorylation | GSGAGGDSAIEQGGQ CCCCCHHHHHHCCCC | 34.13 | 29978859 | |
39 | Phosphorylation | IEQGGQGSALAPSPV HHCCCCCCCCCCCCC | 16.54 | 23927012 | |
44 | Phosphorylation | QGSALAPSPVSGVRR CCCCCCCCCCCCCCC | 32.12 | 23927012 | |
47 | Phosphorylation | ALAPSPVSGVRREGA CCCCCCCCCCCCCCC | 34.65 | 29970186 | |
61 | Methylation | ARGGGRGRGRWKQAG CCCCCCCCCCCCCCC | 30.09 | 18966129 | |
61 | Dimethylation | ARGGGRGRGRWKQAG CCCCCCCCCCCCCCC | 30.09 | - | |
99 | Phosphorylation | RGRGRPPSGGSGLGG CCCCCCCCCCCCCCC | 59.47 | 23532336 | |
116 | Phosphorylation | GGCGGGGSGGGGAPR CCCCCCCCCCCCCCC | 37.22 | 30257219 | |
131 | Phosphorylation | REPVPFPSGSAGPGP CCCCCCCCCCCCCCC | 45.84 | 23312004 | |
133 | Phosphorylation | PVPFPSGSAGPGPRG CCCCCCCCCCCCCCC | 34.10 | 21712546 | |
168 | Phosphorylation | KEEVIRKSGLSAGKS HHHHHHHCCCCCCCC | 34.81 | 20068231 | |
171 | Phosphorylation | VIRKSGLSAGKSDVY HHHHCCCCCCCCCEE | 38.20 | 20068231 | |
175 | Phosphorylation | SGLSAGKSDVYYFSP CCCCCCCCCEEEECC | 31.24 | 20068231 | |
178 | Phosphorylation | SAGKSDVYYFSPSGK CCCCCCEEEECCCCC | 12.09 | 24732914 | |
179 | Phosphorylation | AGKSDVYYFSPSGKK CCCCCEEEECCCCCC | 9.46 | 24732914 | |
181 | Phosphorylation | KSDVYYFSPSGKKFR CCCEEEECCCCCCCC | 11.31 | 23401153 | |
183 | Phosphorylation | DVYYFSPSGKKFRSK CEEEECCCCCCCCCH | 63.14 | 25159151 | |
186 | Ubiquitination | YFSPSGKKFRSKPQL EECCCCCCCCCHHHH | 49.92 | - | |
189 | Phosphorylation | PSGKKFRSKPQLARY CCCCCCCCHHHHHHH | 52.39 | - | |
196 | Phosphorylation | SKPQLARYLGNTVDL CHHHHHHHHCCCCCC | 17.22 | 28152594 | |
217 | Ubiquitination | TGKMMPSKLQKNKQR CCCCCCHHHHHHHHH | 49.41 | - | |
241 | Phosphorylation | KGKPDLNTTLPIRQT CCCCCCCCCCCHHHH | 36.69 | 28555341 | |
242 | Phosphorylation | GKPDLNTTLPIRQTA CCCCCCCCCCHHHHH | 29.48 | 27251275 | |
248 | Phosphorylation | TTLPIRQTASIFKQP CCCCHHHHHHHHCCC | 16.72 | 27251275 | |
250 | Phosphorylation | LPIRQTASIFKQPVT CCHHHHHHHHCCCEE | 31.76 | 24719451 | |
253 | Sumoylation | RQTASIFKQPVTKVT HHHHHHHCCCEEEEC | 52.61 | - | |
253 | Acetylation | RQTASIFKQPVTKVT HHHHHHHCCCEEEEC | 52.61 | 22639661 | |
253 | Sumoylation | RQTASIFKQPVTKVT HHHHHHHCCCEEEEC | 52.61 | - | |
257 | Phosphorylation | SIFKQPVTKVTNHPS HHHCCCEEEECCCCC | 26.87 | 27251275 | |
260 | Phosphorylation | KQPVTKVTNHPSNKV CCCEEEECCCCCCCC | 29.39 | 27251275 | |
264 | Phosphorylation | TKVTNHPSNKVKSDP EEECCCCCCCCCCCH | 41.55 | 22210691 | |
269 | Phosphorylation | HPSNKVKSDPQRMNE CCCCCCCCCHHHHCC | 58.47 | 20860994 | |
285 | 2-Hydroxyisobutyrylation | PRQLFWEKRLQGLSA HHHHHHHHHHCCCCH | 49.34 | - | |
293 | Phosphorylation | RLQGLSASDVTEQII HHCCCCHHHHHHHHH | 29.27 | - | |
296 | Phosphorylation | GLSASDVTEQIIKTM CCCHHHHHHHHHHHC | 27.45 | - | |
381 | Ubiquitination | ERVQQVRKKLEEALM HHHHHHHHHHHHHHH | 63.95 | - | |
382 | Ubiquitination | RVQQVRKKLEEALMA HHHHHHHHHHHHHHH | 51.03 | - | |
398 | Phosphorylation | ILSRAADTEEMDIEM HHHHHCCCCCCCCCC | 29.17 | 20873877 | |
407 | Phosphorylation | EMDIEMDSGDEA--- CCCCCCCCCCCC--- | 47.00 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MBD2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MBD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MBD2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-407, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND MASSSPECTROMETRY. |